No Data
No Data
No Data
No Data
No Data
Hongbo Pharmaceutical (301230.SZ): Net profit of 3.667,700 yuan in the first quarter decreased by 75.99% year-on-year
On April 25, Ge Longhui Pharmaceutical (301230.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 131 million yuan, up 7.69% year on year; net profit attributable to shareholders of listed companies was 36.677 million yuan, down 75.99% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 625,500 yuan, down 95.45% year on year; basic earnings per share were 0.03 yuan.
Gelonghui FinanceApr 25 09:23 ET
The Price Is Right For PharmaResources (Shanghai) Co., Ltd. (SZSE:301230) Even After Diving 26%
PharmaResources (Shanghai) Co., Ltd. (SZSE:301230) shareholders won't be pleased to see that the share price has had a very rough month, dropping 26% and undoing the prior period's positive performanc
Simply Wall StApr 24 21:07 ET
Hongbo Pharmaceutical (301230.SZ) announced its 2023 annual results, with net profit of 376.192 million yuan, a year-on-year decrease of 44%
Hongbo Pharmaceutical (301230.SZ) announced its 2023 annual results. The company achieved operating income of 4.9 during the period...
Zhitong FinanceApr 23 08:47 ET
Jiang Shengli, director of Hongbo Pharmaceutical (301230.SZ), received a warning letter from the Shanghai Securities Regulatory Bureau
Hongbo Pharmaceutical (301230.SZ) announced that Jiang Shengli, the company's director and board secretary, recently received a Chinese certificate...
Zhitong FinanceApr 1 08:24 ET
Hongbo Pharmaceutical (301230.SZ): A total cost of 178.587 million yuan to buy back 0.5847% of the shares
Gelonghui, April 1, 丨 Hongbo Pharmaceutical (301230.SZ) announced that as of March 31, 2024, the company had repurchased a total of 629,300 shares through a dedicated securities account, accounting for 0.5847% of the company's current total share capital of 107,622,666 shares. The highest transaction price was 37.68 yuan/share, and the lowest transaction price was 26.82 yuan/share. The total transaction amount was 17,858,707.12 yuan (excluding transaction fees).
Gelonghui FinanceApr 1 08:11 ET
Hongbo Pharmaceutical (301230.SZ): Initial repurchase of 140,300 shares involving 3.9938 million yuan
Gelonghui, Feb. 21丨Hongbo Pharmaceutical (301230.SZ) announced that on February 20, 2024, for the first time, the company repurchased 140,300 shares of the company's shares through a special stock repurchase securities account, accounting for 0.13% of the company's current total share capital. The highest transaction price was 28.50 yuan/share, the lowest transaction price was 28.28 yuan/share, and the total transaction amount was 3.9938 million yuan (excluding transaction fees).
Gelonghui FinanceFeb 21 05:25 ET
No Data
No Data